Resolution criterion
PROCEED-AD or comparable senescence-targeted clinical readout (target 2027): does combined senolytic depletion (e.g. dasatinib + quercetin) outperform sustained SASP-modulation (e.g. JAK inhibition) on cognitive endpoints in MCI/early-AD over a 24-month window?
- Eliminate (senolytic) hypothesis:h-58e4635a 0 tok · 0 bettors
- Modulate (senomorphic) hypothesis:SDA-2026-04-16-hyp-daadc5c6 0 tok · 0 bettors
Total 0 tokens staked across 2 sides.
Place a bet
Sign in to stake tokens on a side. Bets stake your tokens against the losing side's pool — zero-sum at resolution.
Discussion
No comments yet — be the first.